ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
266 Port Road,
South Australia 5007
Ph: 1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
ME/CFS appears to be a disease affecting the basal banglia and dopamine metabolism
Thursday 17 May 2012
A new study led by CDC investigator Elizabeth Unger, MD, PhD, with collaborators at Emory University, Atlanta, and the University of Modena and Reggio Emilia, Italy, has identified unique responses in the brain’s basal ganglia that suggest an association between a biologic functional response and chronic fatigue syndrome (ME/CFS).
In a paper presented April 24 at the Experimental Biology conference in San Diego,(1) the team reports that:
How the Study Came About
Dr. Unger (chief of the CDC’s Viral Diseases Branch) says that she and her colleagues became curious about the role of the basal ganglia after previous studies by collaborators at Emory University showed that patients treated with interferon alpha, a common treatment for chronic hepatitis C and several other conditions, often experienced extreme fatigue.
Interferons are proteins that cells make to trigger immune defenses in response to pathogens such as viruses, and tumor cells. They ‘interfere’ with viral replication within host cells and activate immune cells.
Further investigation into this phenomenon showed that basal ganglia activity decreased in patients who received this immune therapy.
Since the fatigue induced by interferon alpha shares many characteristics with chronic fatigue syndrome, Dr. Unger and her colleagues decided to investigate whether the basal ganglia were also affected in this disorder.
More Muted Reaction to Stimulus = More Fatigue
The researchers showed that patients with chronic fatigue syndrome experienced significantly less change in basal ganglia blood flow between winning and losing than the healthy volunteers. (Stimulating activities can normally produce ‘razzle-dazzle’ activity in the basal ganglia, says one leading researcher.)
When the researchers looked at scores for the Multidimensional Fatigue Inventory, a survey often used to document fatigue for chronic fatigue syndrome and various other conditions, they also found that the extent of a patient’s fatigue was tightly tied with the change in brain activity between winning and losing.
Those with the most fatigue had the smallest change in brain activity.
Dopamine Dysfunction Involved; Inflammation Possible Cause
These findings add to our understanding of biological factors that may play a role in chronic fatigue syndrome, Dr. Unger says.
“Many patients with chronic fatigue syndrome encounter a lot of skepticism about their illness,” she says. “They have difficulty getting their friends, colleagues, coworkers, and even some physicians to understand their illness. These results provide another clue into the biology of chronic fatigue syndrome.”
The study also suggests some areas of further research that could help scientists develop treatments for this condition in the future.
These results shed some important light on the riddle of ME/CFS - information that researchers hope may eventually lead to better treatments for chronic fatigue syndrome.
* The study was conducted by Elizabeth R. Unger, James F. Jones, and Hao Tian of the Centers for Disease Control and Prevention (CDC); Andrew H. Miller and Daniel F. Drake of Emory University School of Medicine, and Giuseppe Pagnoni of the University of Modena and Reggio Emilia.
They discussed an abstract of their study - entitled “Decreased Basal Ganglia Activation in Chronic Fatigue Syndrome Subjects is Associated with Increased Fatigue” – on April 24 at the Experimental Biology Conference 2012 in San Diego.
The abstract is sponsored by the American Society for Investigative Pathology (ASIP).
Source: Based on a Federation of American Societies for Experimental Biology (FASB) news release, Apr 24, 2012
The above, with comments, originally appeared here.
blog comments powered by Disqus